Vineet Laboratories Limited (VINEETLAB) - Total Liabilities

Latest as of September 2025: Rs764.24 Million INR ≈ $8.26 Million USD

Based on the latest financial reports, Vineet Laboratories Limited (VINEETLAB) has total liabilities worth Rs764.24 Million INR (≈ $8.26 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Vineet Laboratories Limited to evaluate the company's liquid asset resilience ratio.

Vineet Laboratories Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Vineet Laboratories Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see VINEETLAB asset base.

Vineet Laboratories Limited Competitors by Total Liabilities

The table below lists competitors of Vineet Laboratories Limited ranked by their total liabilities.

Company Country Total Liabilities
IDeA Indonesia Akademi Tbk PT
JK:IDEA
Indonesia Rp13.20 Billion
Creative Media & Community Trust Corporation
NASDAQ:CMCT
USA $536.98 Million
Finansa Public Company Limited
BK:FNS
Thailand ฿1.35 Billion
Equity Story Group Ltd
AU:EQS
Australia AU$2.69 Million
Newport Exploration
V:NWX
Canada CA$29.55K
BAWAT WATER TECHNOLOGIES
F:M5W
Germany €28.66 Million
Imunon Inc
NASDAQ:IMNN
USA $10.80 Million
Dnonce Tech Bhd
KLSE:7114
Malaysia RM125.54 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Vineet Laboratories Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Vineet Laboratories Limited's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 5.37 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.84 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vineet Laboratories Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vineet Laboratories Limited (2017–2025)

The table below shows the annual total liabilities of Vineet Laboratories Limited from 2017 to 2025.

Year Total Liabilities Change
2025-03-31 Rs798.92 Million
≈ $8.64 Million
-2.75%
2024-03-31 Rs821.48 Million
≈ $8.88 Million
-0.02%
2023-03-31 Rs821.66 Million
≈ $8.89 Million
-18.17%
2022-03-31 Rs1.00 Billion
≈ $10.86 Million
+22.27%
2021-03-31 Rs821.26 Million
≈ $8.88 Million
+20531525.00%
2020-03-31 Rs4.00K
≈ $43.26
-94.65%
2019-03-31 Rs74.78K
≈ $808.72
-35.80%
2018-03-31 Rs116.48K
≈ $1.26K
+1064.80%
2017-03-31 Rs10.00K
≈ $108.15
--

About Vineet Laboratories Limited

NSE:VINEETLAB India Chemicals
Market Cap
$7.64 Million
Rs706.41 Million INR
Market Cap Rank
#27809 Global
#1548 in India
Share Price
Rs36.78
Change (1 day)
+2.25%
52-Week Range
Rs29.01 - Rs47.87
All Time High
Rs117.46
About

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl… Read more